STAT October 17, 2021
Fredros Okumu

Historic yet imperfect. That’s how I think of the World Health Organization’s recent endorsement of the long-awaited malaria vaccine, officially known as RTS,S/AS01, or simply as RTS,S.

This recommendation follows careful determination by two of the WHO’s high-level advisory panels, one on immunization and another on malaria, that RTS,S provides significant protection against disease and deaths and that it is safe and cost-effective.

That’s a huge step forward for a disease with 230 million cases in 2019, the last year with compete statistics, one that killed 409,000 people. Although malaria is most common in sub-Saharan Africa, it is also endemic in southeast Asia, the eastern Mediterranean, western Pacific, and Central and South America.

The WHO’s final recommendation follows an ongoing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Why nurses are protesting AI
CVS invests $19M for affordable housing in Colorado
U.S. expands testing for bird flu in dairy cows
What Fishing Can Teach Us About Lowering Healthcare Costs
Bridging Public Health and Social Movements

Share This Article